Financial Ratios LG Chem, Ltd.

Equities

A051910

KR7051910008

Commodity Chemicals

End-of-day quote Korea S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
326,500.00 ^KRW	+0.62%		-16.28%	-1.95%

07:06am	S&P Revises Outlook on LG Chem, LG Energy Solution to Negative on Weak EV Demand, Subdued Chemical Sector	MT
03-05	LG Chem to Unveil Integrated Battery Safety Product at InterBattery 2026; Shares Jump 7%	MT

3f94e0558c9ca58dd0c664a.1kB2uORfn10AEhUx2cZQJ1s_N7rW6kJc6FgGZ_SL2A8.jjA_jaoe2BxaXkZVs402ah1WXuyYrRBlnRNAVMPnv0u-EU-OvDv1Cm5kLQ

Published financial data: LG CHEM, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	30,077B	42,655B	51,865B	55,250B	48,916B
Total Revenues	30,077B	42,655B	51,865B	55,250B	48,916B
Cost of Goods Sold, Total	23,763B	31,436B	41,878B	46,462B	41,377B
Gross Profit	6,313B	11,218B	9,986B	8,788B	7,539B
Selling General & Admin Expenses, Total	3,971B	5,525B	6,080B	5,777B	6,727B
R&D Expenses	218B	255B	385B	475B	577B
Depreciation & Amortization - (IS)	192B	245B	296B	362B	425B
Amortization of Goodwill and Intangible Assets - (IS)	134B	168B	230B	322B	373B
Other Operating Expenses	-	-	-	-677B	-1,480B
Other Operating Expenses, Total	4,515B	6,193B	6,991B	6,258B	6,622B
Operating Income	1,798B	5,025B	2,996B	2,529B	917B
Interest Expense, Total	-199B	-211B	-303B	-647B	-954B
Interest And Investment Income	36.22B	83.12B	267B	341B	363B
Net Interest Expenses	-163B	-128B	-35.8B	-306B	-591B
Income (Loss) On Equity Invest.	9.34B	-511M	-46.22B	-33.31B	-24.86B
Currency Exchange Gains (Loss)	-371B	42.11B	-161B	466B	-537B
Other Non Operating Income (Expenses)	-351B	243B	17.81B	79.77B	849B
EBT, Excl. Unusual Items	923B	5,182B	2,771B	2,736B	613B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	312B	-	-	-	105B
Gain (Loss) On Sale Of Assets	-78.98B	-25.91B	-25.41B	-40.99B	-206B
Asset Writedown	-212B	-328B	-64.66B	-204B	-791B
Insurance Settlements	-	62.65B	132B	15.64B	21.88B
Other Unusual Items	-	-	-	-8.18B	-10.05B
EBT, Incl. Unusual Items	944B	4,891B	2,813B	2,498B	-268B
Income Tax Expense	368B	1,236B	641B	433B	61.04B
Earnings From Continuing Operations	576B	3,655B	2,171B	2,066B	-329B
Earnings Of Discontinued Operations	107B	299B	24.45B	-9.95B	843B
Net Income to Company	682B	3,954B	2,196B	2,056B	514B
Minority Interest	-170B	-284B	-350B	-718B	-1,205B
Net Income - (IS)	513B	3,670B	1,845B	1,338B	-691B
Preferred Dividend and Other Adjustments	-	362B	182B	-	-
Net Income to Common Incl Extra Items	513B	3,308B	1,663B	1,338B	-691B
Net Income to Common Excl. Extra Items	406B	3,009B	1,639B	1,348B	-1,534B
Per Share Items
Net EPS - Basic	6.67K	42.47K	21.34K	17.09K	-8.83K
Basic EPS - Continuing Operations	5.28K	38.63K	21.02K	17.22K	-19.6K
Basic Weighted Average Shares Outstanding	76.85M	77.89M	77.94M	78.28M	78.28M
Net EPS - Diluted	6.67K	42.47K	21.34K	17.09K	-8.83K
Diluted EPS - Continuing Operations	5.28K	38.63K	21.02K	17.22K	-19.6K
Diluted Weighted Average Shares Outstanding	76.85M	77.89M	77.94M	78.28M	78.28M
Normalized Basic EPS	5.3K	37.93K	17.72K	12.67K	-10.5K
Normalized Diluted EPS	5.3K	37.93K	17.72K	12.67K	-10.5K
Dividend Per Share	10K	12K	10K	3.5K	1K
Payout Ratio	29.96	23.7	59.12	82.53	-53.17
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	4,073B	7,866B	6,392B	6,443B	5,578B
EBITA	1,979B	5,249B	3,287B	2,914B	1,391B
EBIT	1,798B	5,025B	2,996B	2,529B	917B
EBITDAR	4,161B	-	-	6,597B	5,727B
Effective Tax Rate - (Ratio)	38.98	25.27	22.81	17.31	-22.77
Total Current Taxes	113B	-	-	706B	775B
Total Deferred Taxes	234B	-	-	-300B	-700B
Normalized Net Income	407B	2,955B	1,382B	992B	-822B
Interest Capitalized	47.06B	45.89B	20.06B	91.12B	150B
Interest on Long-Term Debt	246B	-	-	737B	604B
Non-Cash Pension Expense	4.01B	2.06B	-779M	-32.01B	-22.3B
Supplemental Operating Expense Items
Advertising Expense	28.46B	39.06B	48.8B	78.48B	89.26B
Marketing Expenses	21.47B	20.95B	25.33B	31.23B	42.03B
Selling and Marketing Expenses	1,346B	1,909B	2,688B	2,101B	2,182B
General and Administrative Expenses	16.01B	28.37B	49.44B	62B	47.48B
Research And Development Expense From Footnotes	1,116B	255B	385B	2,033B	2,157B
Net Rental Expense, Total	87.94B	-	-	154B	149B
Imputed Operating Lease Interest Expense	18.6B	-	-	47.97B	53.2B
Imputed Operating Lease Depreciation	69.34B	-	-	106B	95.35B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3,274B	3,761B	8,498B	9,085B	7,855B
Short Term Investments	608B	-	14.45B	57.11B	213B
Trading Asset Securities, Total	-	64.58B	9.17B	-	-
Total Cash And Short Term Investments	3,882B	3,825B	8,521B	9,142B	8,068B
Accounts Receivable, Total	5,298B	6,387B	7,450B	8,083B	8,166B
Other Receivables	274B	898B	556B	582B	861B
Notes Receivable	-	65.27B	130B	-	-
Total Receivables	5,573B	7,350B	8,136B	8,665B	9,027B
Inventory	5,350B	8,283B	11,881B	9,375B	8,847B
Prepaid Expenses	175B	466B	294B	-	-
Other Current Assets, Total	1,340B	484B	815B	1,677B	1,873B
Total Current Assets	16,320B	20,408B	29,647B	28,859B	27,816B
Gross Property Plant And Equipment	34,913B	41,029B	48,903B	60,490B	80,401B
Accumulated Depreciation	-14,346B	-16,651B	-19,240B	-21,540B	-25,831B
Net Property Plant And Equipment	20,567B	24,378B	29,663B	38,950B	54,570B
Long-term Investments	391B	1,165B	2,185B	2,295B	2,880B
Goodwill	887B	804B	786B	1,061B	801B
Other Intangibles, Total	1,337B	1,590B	1,860B	2,597B	2,779B
Accounts Receivable Long-Term	29.38B	67.06B	121B	130B	393B
Loans Receivable Long-Term	831M	331B	207B	9.89B	15.67B
Deferred Tax Assets Long-Term	1,410B	1,905B	2,166B	2,309B	2,866B
Deferred Charges Long-Term	55.86B	49.95B	43.66B	35.18B	38.63B
Other Long-Term Assets, Total	391B	437B	1,296B	1,220B	1,699B
Total Assets	41,389B	51,135B	67,974B	77,467B	93,858B
Liabilities
Accounts Payable, Total	3,459B	3,742B	4,756B	4,118B	3,682B
Accrued Expenses, Total	393B	700B	811B	477B	391B
Short-term Borrowings	880B	1,688B	1,402B	-	1,812B
Current Portion of Long-Term Debt	614B	1,717B	2,307B	6,978B	5,668B
Current Portion of Leases	55.39B	71.86B	95.08B	100B	141B
Current Income Taxes Payable	373B	958B	626B	45.3B	184B
Unearned Revenue Current, Total	62.29B	104B	149B	119B	90.94B
Other Current Liabilities	6,788B	6,081B	6,313B	6,553B	9,116B
Total Current Liabilities	12,624B	15,062B	16,460B	18,391B	21,086B
Long-Term Debt	8,508B	11,041B	11,866B	14,459B	18,981B
Long-Term Leases	129B	247B	295B	392B	774B
Unearned Revenue Non Current	14.95B	99.17B	225B	163B	103B
Pension & Other Post Retirement Benefits	118B	18.12B	19.47B	11.88B	9.79B
Deferred Tax Liability Non Current	690B	714B	839B	735B	433B
Other Non Current Liabilities	514B	743B	790B	2,377B	4,476B
Total Liabilities	22,598B	27,925B	30,493B	36,529B	45,862B
Common Stock, Total	391B	391B	391B	391B	391B
Additional Paid In Capital	2,692B	2,696B	11,363B	11,572B	11,569B
Retained Earnings	15,175B	18,092B	19,142B	19,651B	18,592B
Treasury Stock	-35.7B	-18.01B	-270M	-270M	-270M
Comprehensive Income and Other	-184B	532B	554B	579B	2,732B
Total Common Equity	18,039B	21,694B	31,451B	32,193B	33,284B
Minority Interest	751B	1,516B	6,031B	8,746B	14,711B
Total Equity	18,790B	23,210B	37,481B	40,938B	47,995B
Total Liabilities And Equity	41,389B	51,135B	67,974B	77,467B	93,858B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	77.8M	77.91M	78.28M	78.28M	78.28M
ECS Total Common Shares Outstanding	77.8M	77.91M	78.28M	78.28M	78.28M
Book Value / Share	232K	278K	402K	411K	425K
Tangible Book Value	15,815B	19,299B	28,804B	28,535B	29,703B
Tangible Book Value Per Share	203K	248K	368K	365K	379K
Total Debt	10,186B	14,766B	15,965B	21,928B	27,376B
Net Debt	6,304B	10,940B	7,443B	12,786B	19,308B
Debt Equivalent of Unfunded Proj. Benefit Obligation	118B	-26.93B	-599B	-483B	-207B
Debt Equivalent Oper. Leases	704B	-	-	1,231B	1,188B
Minority Interest, Total (Incl. Fin. Div)	751B	1,516B	6,031B	8,746B	14,711B
Equity Method Investments, Total	309B	535B	950B	1,006B	898B
Account Code - Inventory Valuation	8	-	-	6	6
Inventories - Raw Materials, Total	2,069B	2,307B	3,312B	3,682B	3,554B
Inventories - Work In Process, Total	23.57B	25.59B	32.44B	18.44B	26.23B
Inventories - Finished Goods, Total	3,218B	6,215B	8,944B	5,705B	5,329B
Inventories - Others	189B	-	-	342B	362B
Land - (BS)	1,772B	1,852B	1,964B	2,010B	2,139B
Buildings, Total	7,405B	8,577B	10,378B	11,979B	15,422B
Machinery, Total	21,094B	25,742B	28,862B	31,764B	37,835B
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	4.39B	5.09B	5.02B	2.81B	2.44B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	513B	3,670B	1,845B	1,338B	-691B
Depreciation & Amortization - CF	2,095B	2,618B	3,105B	3,529B	4,188B
Amortization of Goodwill and Intangible Assets - (CF)	180B	223B	291B	385B	474B
Depreciation & Amortization, Total	2,275B	2,841B	3,396B	3,914B	4,662B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	30.71B	17.74B	25.05B	160B	-589B
(Gain) Loss on Sale of Investments - (CF)	-312B	-	-	14.56B	-94.22B
Asset Writedown & Restructuring Costs	214B	329B	64.66B	204B	791B
(Income) Loss On Equity Investments - (CF)	-	-6.1B	-46.22B	-33.31B	24.86B
Net Cash From Discontinued Operations	201B	376B	29.76B	36.14B	882B
Other Operating Activities, Total	1,653B	1,289B	571B	488B	579B
Change In Accounts Receivable	-3,182B	-654B	-1,447B	-300B	618B
Change In Inventories	-566B	-2,816B	-3,818B	2,965B	1,119B
Change In Accounts Payable	3,652B	289B	1,147B	-982B	-1,119B
Change in Other Net Operating Assets	1,362B	174B	-1,199B	-268B	831B
Cash from Operations	5,841B	5,510B	570B	7,536B	7,012B
Capital Expenditure	-5,536B	-5,774B	-8,406B	-12,960B	-14,615B
Sale of Property, Plant, and Equipment	131B	85.62B	82.16B	147B	122B
Cash Acquisitions	-184B	386B	-8.99B	-702B	59.82B
Divestitures	354B	1M	49.78B	155B	793B
Sale (Purchase) of Intangible assets	-106B	-129B	-143B	-151B	-153B
Investment in Marketable and Equity Securities, Total	412B	-448B	-1,150B	-362B	-431B
Other Investing Activities, Total	-367B	529B	348B	704B	560B
Cash from Investing	-5,296B	-5,349B	-9,229B	-13,170B	-13,663B
Long-Term Debt Issued, Total	4,074B	5,661B	5,322B	13,166B	10,443B
Total Debt Issued	4,074B	5,661B	5,322B	13,166B	10,443B
Long-Term Debt Repaid, Total	-3,195B	-5,106B	-4,822B	-8,117B	-8,621B
Total Debt Repaid	-3,195B	-5,106B	-4,822B	-8,117B	-8,621B
Issuance of Common Stock	-	8.84B	257B	-	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-154B	-870B	-1,091B	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-1,104B	-367B
Common & Preferred Stock Dividends Paid	-154B	-870B	-1,091B	-1,104B	-367B
Other Financing Activities, Total	213B	429B	13,666B	2,212B	3,367B
Cash from Financing	938B	124B	13,332B	6,158B	4,821B
Foreign Exchange Rate Adjustments	-84.41B	202B	64.53B	86.56B	576B
Miscellaneous Cash Flow Adjustments	-12.5B	-	-	-23.88B	23.88B
Net Change in Cash	1,386B	487B	4,737B	587B	-1,230B
Supplemental Items
Cash Interest Paid	216B	223B	304B	646B	939B
Cash Income Tax Paid (Refund)	513B	1,282B	1,707B	1,348B	660B
Levered Free Cash Flow	-1,366B	-4,292B	-6,947B	-7,918B	-8,007B
Unlevered Free Cash Flow	-1,242B	-4,160B	-6,758B	-7,514B	-7,411B
Change In Net Working Capital	-1,001B	4,239B	3,477B	-103B	-2,122B
Net Debt Issued / Repaid	879B	555B	500B	5,050B	1,822B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.98	6.79	3.14	2.17	0.67
Return on Total Capital	4.1	9.38	4.1	2.72	0.83
Return On Equity %	3.18	17.4	7.15	5.27	-0.74
Return on Common Equity	2.32	15.15	6.17	4.24	-4.69
Margin Analysis
Gross Profit Margin %	20.99	26.3	19.25	15.9	15.41
SG&A Margin	13.2	12.95	11.72	10.46	13.75
EBITDA Margin %	13.54	18.44	12.32	11.66	11.4
EBITA Margin %	6.58	12.3	6.34	5.27	2.84
EBIT Margin %	5.98	11.78	5.78	4.58	1.87
Income From Continuing Operations Margin %	1.91	8.57	4.19	3.74	-0.67
Net Income Margin %	1.7	8.6	3.56	2.42	-1.41
Net Avail. For Common Margin %	1.35	7.05	3.16	2.44	-3.14
Normalized Net Income Margin	1.35	6.93	2.66	1.8	-1.68
Levered Free Cash Flow Margin	-4.54	-10.06	-13.4	-14.33	-16.37
Unlevered Free Cash Flow Margin	-4.13	-9.75	-13.03	-13.6	-15.15
Asset Turnover
Asset Turnover	0.8	0.92	0.87	0.76	0.57
Fixed Assets Turnover	1.54	1.9	1.92	1.61	1.05
Receivables Turnover (Average Receivables)	6.66	7.3	7.5	7.11	6.02
Inventory Turnover (Average Inventory)	4.58	4.61	4.15	4.37	4.54
Short Term Liquidity
Current Ratio	1.29	1.35	1.8	1.57	1.32
Quick Ratio	0.75	0.74	1	0.97	0.81
Operating Cash Flow to Current Liabilities	0.46	0.37	0.03	0.41	0.33
Days Sales Outstanding (Average Receivables)	54.98	50	48.69	51.31	60.79
Days Outstanding Inventory (Average Inventory)	79.96	79.15	87.87	83.49	80.59
Average Days Payable Outstanding	44.37	38.23	34.1	36.84	34.94
Cash Conversion Cycle (Average Days)	90.58	90.91	102.46	97.96	106.44
Long Term Solvency
Total Debt/Equity	54.21	63.62	42.59	53.56	57.04
Total Debt / Total Capital	35.15	38.88	29.87	34.88	36.32
LT Debt/Equity	45.97	48.64	32.44	36.28	41.16
Long-Term Debt / Total Capital	29.81	29.73	22.75	23.62	26.21
Total Liabilities / Total Assets	54.6	54.61	44.86	47.15	48.86
EBIT / Interest Expense	9.04	23.82	9.88	3.91	0.96
EBITDA / Interest Expense	20.49	37.28	21.09	9.95	5.85
(EBITDA - Capex) / Interest Expense	-7.36	9.92	-6.65	-10.07	-9.47
Total Debt / EBITDA	2.5	1.88	2.5	3.4	4.91
Net Debt / EBITDA	1.55	1.39	1.16	1.98	3.46
Total Debt / (EBITDA - Capex)	-6.96	7.06	-7.92	-3.36	-3.03
Net Debt / (EBITDA - Capex)	-4.31	5.23	-3.69	-1.96	-2.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.96	41.9	21.75	8.37	-11.46
Gross Profit, 1 Yr. Growth %	34.7	77.58	-10.95	-10.9	-14.21
EBITDA, 1 Yr. Growth %	55.17	91.1	-18.76	1.8	-13.42
EBITA, 1 Yr. Growth %	105.82	164.24	-37.39	-10.49	-52.28
EBIT, 1 Yr. Growth %	117.85	178.36	-40.4	-15.11	-63.75
Earnings From Cont. Operations, 1 Yr. Growth %	42.09	526.09	-40.62	-3.53	-115.93
Net Income, 1 Yr. Growth %	63.59	615.87	-49.71	-27.5	-151.64
Normalized Net Income, 1 Yr. Growth %	4.05	391.25	-53.26	-26.92	-183.1
Diluted EPS Before Extra, 1 Yr. Growth %	24.2	617.07	-51.44	-24.94	-213.83
Accounts Receivable, 1 Yr. Growth %	41.73	20.55	16.65	8.49	1.03
Inventory, 1 Yr. Growth %	6.28	54.84	43.43	-21.09	-5.63
Net Property, Plant and Equip., 1 Yr. Growth %	10.62	18.53	21.68	31.31	40.1
Total Assets, 1 Yr. Growth %	21.64	23.55	32.93	13.97	21.16
Tangible Book Value, 1 Yr. Growth %	6.46	22.03	49.25	-0.93	4.1
Common Equity, 1 Yr. Growth %	6.08	20.26	44.98	2.36	3.39
Cash From Operations, 1 Yr. Growth %	87.14	-5.67	-89.66	1.22K	-6.95
Capital Expenditures, 1 Yr. Growth %	-11.26	4.3	45.6	54.17	12.77
Levered Free Cash Flow, 1 Yr. Growth %	-50.73	494.25	62.07	-	1.12
Unlevered Free Cash Flow, 1 Yr. Growth %	-53.06	595.21	62.66	-	-1.37
Dividend Per Share, 1 Yr. Growth %	400	20	-16.67	-65	-71.43
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.3	24.88	31.36	-	-2.05
Gross Profit, 2 Yr. CAGR %	8.65	54.71	25.73	-	-12.57
EBITDA, 2 Yr. CAGR %	5.05	73.11	24.61	-	-6.12
EBITA, 2 Yr. CAGR %	-7.49	133.66	28.63	-	-34.64
EBIT, 2 Yr. CAGR %	-10.52	146.75	28.82	-	-44.53
Earnings From Cont. Operations, 2 Yr. CAGR %	-38.44	200.31	92.85	-	-60.8
Net Income, 2 Yr. CAGR %	-41	242.21	89.73	-	-38.81
Normalized Net Income, 2 Yr. CAGR %	-42.23	174.79	51.56	-	-22.18
Diluted EPS Before Extra, 2 Yr. CAGR %	-47.35	201.32	97.55	-	-7.56
Accounts Receivable, 2 Yr. CAGR %	9.97	30.71	18.58	-	4.69
Inventory, 2 Yr. CAGR %	11.68	28.28	49.02	-	-13.7
Net Property, Plant and Equip., 2 Yr. CAGR %	21.91	14.5	20.09	-	35.64
Total Assets, 2 Yr. CAGR %	19.58	22.59	28.15	-	17.51
Tangible Book Value, 2 Yr. CAGR %	1.68	13.98	34.96	-	1.55
Common Equity, 2 Yr. CAGR %	2.76	12.95	32.04	-	2.87
Cash From Operations, 2 Yr. CAGR %	65.79	32.87	-68.76	-	250.78
Capital Expenditures, 2 Yr. CAGR %	14.54	-3.8	23.23	-	31.85
Levered Free Cash Flow, 2 Yr. CAGR %	-8.42	24.39	210.15	-	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-10.32	25.37	236.07	-	-
Dividend Per Share, 2 Yr. CAGR %	29.1	144.95	0	-	-68.38
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.38	14.81	23.77	22.47	-
Gross Profit, 3 Yr. CAGR %	4.3	28.01	28.68	11.65	-
EBITDA, 3 Yr. CAGR %	-1.77	28.69	34.53	16.52	-
EBITA, 3 Yr. CAGR %	-12.87	31.43	50.65	13.78	-
EBIT, 3 Yr. CAGR %	-15	30.79	53.68	12.04	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-34.21	33.99	74.98	53.08	-
Net Income, 3 Yr. CAGR %	-35.89	35.58	80.58	37.68	-
Normalized Net Income, 3 Yr. CAGR %	-37.11	34.29	52.27	34.57	-
Diluted EPS Before Extra, 3 Yr. CAGR %	-40.74	26.54	70.33	48.25	-
Accounts Receivable, 3 Yr. CAGR %	6	13.39	25.85	15.12	-
Inventory, 3 Yr. CAGR %	16.86	24.53	33.14	20.56	-
Net Property, Plant and Equip., 3 Yr. CAGR %	22.42	20.77	16.85	23.72	-
Total Assets, 3 Yr. CAGR %	18.23	20.89	25.95	23.24	-
Tangible Book Value, 3 Yr. CAGR %	2.85	8.05	24.7	21.74	-
Common Equity, 3 Yr. CAGR %	3.72	8.29	22.75	21.3	-
Cash From Operations, 3 Yr. CAGR %	22.46	37.38	-43.27	8.87	-
Capital Expenditures, 3 Yr. CAGR %	34.95	11.02	10.45	32.78	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	38.11	35.81	79.61	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	39.13	36.68	82.2	-
Dividend Per Share, 3 Yr. CAGR %	18.56	25.99	71	-29.53	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.28	15.6	15.08	14.41	12.33
Gross Profit, 5 Yr. CAGR %	11.48	22.52	12.41	10.44	9.97
EBITDA, 5 Yr. CAGR %	5.87	18.77	8.27	11.79	16.27
EBITA, 5 Yr. CAGR %	1.38	20.73	1.9	4.74	7.66
EBIT, 5 Yr. CAGR %	-0.28	20.33	0.46	2.4	2.12
Earnings From Cont. Operations, 5 Yr. CAGR %	-12.9	23.33	1.43	6.34	-4.08
Net Income, 5 Yr. CAGR %	-14.97	23.43	-1.05	-1.9	17.13
Normalized Net Income, 5 Yr. CAGR %	-17.65	22.18	-3.33	-4.05	16.01
Diluted EPS Before Extra, 5 Yr. CAGR %	-19.55	17.27	-3.7	-2.01	35.73
Accounts Receivable, 5 Yr. CAGR %	10.36	12.57	10.86	13.03	16.91
Inventory, 5 Yr. CAGR %	18	22.81	28.79	16.93	11.94
Net Property, Plant and Equip., 5 Yr. CAGR %	18.33	20.29	21.48	22.99	24.03
Total Assets, 5 Yr. CAGR %	17.37	20.07	22.11	21.76	22.5
Tangible Book Value, 5 Yr. CAGR %	4.83	7.88	14.66	13.28	14.86
Common Equity, 5 Yr. CAGR %	6.79	9.25	14.23	13.51	14.38
Cash From Operations, 5 Yr. CAGR %	12.99	16.97	-29.1	28.81	17.57
Capital Expenditures, 5 Yr. CAGR %	27.65	32.79	30.13	25.16	18.56
Levered Free Cash Flow, 5 Yr. CAGR %	3.79	48.64	52.52	37.19	23.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.19	45.43	49.52	37.22	22.87
Dividend Per Share, 5 Yr. CAGR %	17.32	-	10.76	-10.22	-12.94